These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 21897248)
21. Characterization of a multifunctional PEG-based gene delivery system containing nuclear localization signals and endosomal escape peptides. Moore NM; Sheppard CL; Sakiyama-Elbert SE Acta Biomater; 2009 Mar; 5(3):854-64. PubMed ID: 18926782 [TBL] [Abstract][Full Text] [Related]
22. Nanomedicine for Inner Ear Diseases: A Review of Recent Kim DK Biomed Res Int; 2017; 2017():3098230. PubMed ID: 29130038 [TBL] [Abstract][Full Text] [Related]
23. Protein kinase A inhibition modulates the intracellular routing of gene delivery vehicles in HeLa cells, leading to productive transfection. ur Rehman Z; Hoekstra D; Zuhorn IS J Control Release; 2011 Nov; 156(1):76-84. PubMed ID: 21787817 [TBL] [Abstract][Full Text] [Related]
24. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise. Bharali DJ; Mousa SA Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093 [TBL] [Abstract][Full Text] [Related]
26. Chemical vectors for gene delivery: uptake and intracellular trafficking. Pichon C; Billiet L; Midoux P Curr Opin Biotechnol; 2010 Oct; 21(5):640-5. PubMed ID: 20674331 [TBL] [Abstract][Full Text] [Related]
27. Development of pH-responsive nanocarriers using trimethylchitosans and methacrylic acid copolymer for siRNA delivery. Dehousse V; Garbacki N; Colige A; Evrard B Biomaterials; 2010 Mar; 31(7):1839-49. PubMed ID: 19948356 [TBL] [Abstract][Full Text] [Related]
28. Nanoparticles as protein and gene carriers to mucosal surfaces. de la Fuente M; Csaba N; Garcia-Fuentes M; Alonso MJ Nanomedicine (Lond); 2008 Dec; 3(6):845-57. PubMed ID: 19025458 [TBL] [Abstract][Full Text] [Related]
29. A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles. Swami A; Kurupati RK; Pathak A; Singh Y; Kumar P; Gupta KC Biochem Biophys Res Commun; 2007 Nov; 362(4):835-41. PubMed ID: 17822674 [TBL] [Abstract][Full Text] [Related]
30. Delivery of nanoparticulate drug delivery systems via the intravenous route for cancer gene therapy. Hallaj-Nezhadi S; Lotfipour F; Dass CR Pharmazie; 2010 Dec; 65(12):855-9. PubMed ID: 21284252 [TBL] [Abstract][Full Text] [Related]
31. To be targeted: is the magic bullet concept a viable option for synthetic nucleic acid therapeutics? Ogris M; Wagner E Hum Gene Ther; 2011 Jul; 22(7):799-807. PubMed ID: 21563983 [TBL] [Abstract][Full Text] [Related]
32. Nanoparticle-mediated gene delivery. Jin S; Leach JC; Ye K Methods Mol Biol; 2009; 544():547-57. PubMed ID: 19488722 [TBL] [Abstract][Full Text] [Related]
33. Enhanced gene transfection efficiency in CD13-positive vascular endothelial cells with targeted poly(lactic acid)-poly(ethylene glycol) nanoparticles through caveolae-mediated endocytosis. Liu C; Yu W; Chen Z; Zhang J; Zhang N J Control Release; 2011 Apr; 151(2):162-75. PubMed ID: 21376765 [TBL] [Abstract][Full Text] [Related]
34. Multifunctional nanocomplexes for gene transfer and gene therapy. Hart SL Cell Biol Toxicol; 2010 Feb; 26(1):69-81. PubMed ID: 20127400 [TBL] [Abstract][Full Text] [Related]
35. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Torchilin VP Biopolymers; 2008; 90(5):604-10. PubMed ID: 18381624 [TBL] [Abstract][Full Text] [Related]
36. [Current progress in researches on the gene delivery systems based on nanoparticles technology]. Qi X; Xu H Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Dec; 26(6):1376-9. PubMed ID: 20095507 [TBL] [Abstract][Full Text] [Related]
37. HVJ envelope vector, a versatile delivery system: its development, application, and perspectives. Zhang Q; Li Y; Shi Y; Zhang Y Biochem Biophys Res Commun; 2008 Aug; 373(3):345-9. PubMed ID: 18588856 [TBL] [Abstract][Full Text] [Related]
38. On the cellular processing of non-viral nanomedicines for nucleic acid delivery: mechanisms and methods. Vercauteren D; Rejman J; Martens TF; Demeester J; De Smedt SC; Braeckmans K J Control Release; 2012 Jul; 161(2):566-81. PubMed ID: 22613879 [TBL] [Abstract][Full Text] [Related]
39. Nanoparticles and microparticles for skin drug delivery. Prow TW; Grice JE; Lin LL; Faye R; Butler M; Becker W; Wurm EM; Yoong C; Robertson TA; Soyer HP; Roberts MS Adv Drug Deliv Rev; 2011 May; 63(6):470-91. PubMed ID: 21315122 [TBL] [Abstract][Full Text] [Related]
40. Anticancer drug delivery with nanoparticles. Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]